201. The role of IL-22 in the resolution of sterile and nonsterile inflammation
- Author
-
Saleh Y. Alabbas, Jakob Begun, Iulia Oancea, and Timothy H. Florin
- Subjects
0301 basic medicine ,T helper 17 cells ,Chemokine ,Special Feature Reviews ,medicine.medical_treatment ,Immunology ,innate lymphoid cells ,inflammatory diseases ,Inflammation ,Interleukin 22 ,03 medical and health sciences ,0302 clinical medicine ,Immune system ,inflammatory bowel disease ,Special Feature Review ,medicine ,Immunology and Allergy ,hepatitis ,General Nursing ,Innate immune system ,biology ,Regeneration (biology) ,Innate lymphoid cell ,interleukins ,030104 developmental biology ,Cytokine ,biology.protein ,medicine.symptom ,030215 immunology - Abstract
In a broad sense, inflammation can be conveniently characterised by two phases: the first phase, which is a pro‐inflammatory, has evolved to clear infection and/or injured tissue; and the second phase concerns regeneration of normal tissue and restitution of normal physiology. Innate immune cell‐derived pro‐inflammatory cytokines and chemokines activate and recruit nonresident immune cells to the site of infection, thereby amplifying the inflammatory responses to clear infection or injury. This phase is followed by a cytokine milieu that promotes tissue regeneration. There is no absolute temporal distinction between these two phases, and cytokines may have dual pleiotropic effects depending on the timing of release, inflammatory microenvironment or concentrations. IL‐22 is a cytokine with reported pro‐ and anti‐inflammatory roles; in this review, we contend that this protein has primarily a function in restitution of normal tissue and physiology.
- Published
- 2018